Double - blind randomized evaluation of intercostal nerve blocks as an adjuvant to subarachnoid administered morphine for post - thoracotomy analgesia . 
<br>
<br> BACKGROUND AND OBJECTIVES Thoracotomy is associated with <font color="blue">pain_1</font> and <font color="blue">compromised_1</font> <font color="blue">pulmonary_1</font> <font color="blue">function_1</font> <font color="blue">._1</font> Intercostal nerve blocks ( INB ) and subarachnoid morphine ( SM ) act on different portions of the pain pathway . Each is effective for post - thoracotomy <font color="blue">pain_1</font> relief . The combination of these two modalities in relieving <font color="blue">post_1</font> <font color="blue">-_1</font> <font color="blue">thoracotomy_1</font> <font color="blue">pain_1</font> and improving <font color="blue">postoperative_1</font> <font color="blue">pulmonary_1</font> <font color="blue">function_1</font> has not been investigated . 
<br> METHODS In a double - blind study , 20 patients undergoing lateral thoracotomy for lung resection were randomized to receive 0.5 mg SM preoperatively and INB with bupivacaine ( INB+ ) prior to wound closure or 0.5 mg SM with INB using saline ( INB- ) . <font color="blue">Visual_1</font> <font color="blue">analog_1</font> <font color="blue">scale_1</font> <font color="blue">pain_2</font> <font color="blue">scores_2</font> <font color="blue">at_1</font> <font color="blue">rest_1</font> <font color="blue">,_1</font> <font color="blue">with_2</font> <font color="blue">cough_2</font> <font color="blue">,_2</font> <font color="blue">and_2</font> <font color="blue">with_2</font> <font color="blue">movement_2</font> <font color="blue">of_2</font> <font color="blue">the_2</font> <font color="blue">ipsilateral_2</font> <font color="blue">arm_2</font> <font color="blue">,_2</font> <font color="blue">forced_2</font> <font color="blue">expiratory_2</font> <font color="blue">volume_2</font> <font color="blue">in_2</font> <font color="blue">1_2</font> <font color="blue">second_2</font> <font color="blue">(_2</font> <font color="blue">FEV1_2</font> <font color="blue">)_2</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">forced_2</font> <font color="blue">vital_2</font> <font color="blue">capacity_2</font> <font color="blue">(_2</font> <font color="blue">FVC_2</font> <font color="blue">)_2</font> were measured at 4 , 24 , 48 , and 72 hours after the operation . <font color="blue">Opioid_1</font> <font color="blue">use_1</font> was measured during the initial 24 hours after the operation . 
<br> RESULTS At 4 hours , the INB+ group demonstrated better <font color="blue">FEV1_2</font> ( 56.6% vs. 40.4% of baseline , P < .05 ) and <font color="blue">FVC_1</font> values ( 54.6% vs. 39.6% of baseline , P < .05 ) and less <font color="blue">resting_1</font> <font color="blue">and_1</font> <font color="blue">cough_1</font> <font color="blue">pain_1</font> ( P < .05 ) . However , <font color="blue">FEV1_3</font> continued to decline in the INB+ group at 24 hours to lower than the INB- group although <font color="blue">pain_2</font> <font color="blue">scores_2</font> were similar beyond 4 hours . <font color="blue">Opioid_3</font> <font color="blue">usage_3</font> <font color="blue">during_1</font> <font color="blue">the_1</font> <font color="blue">first_1</font> <font color="blue">24_1</font> <font color="blue">hours_1</font> was similar ( INB- , 16.7 mg vs. INB+ , 13.2 mg , P = .7 ) . 
<br> CONCLUSIONS Although postoperative INB provided modest improvements in pain and pulmonary function when used as an adjuvant to 0.5 mg SM for post - thoracotomy <font color="blue">analgesia_1</font> <font color="blue">,_1</font> the benefits were transient . The authors do not recommend adding INB for patients undergoing lateral thoracotomy who receive 0.5 mg SM .